Search results for PX-TA1265

Showing 1 – 10 of1products
Urelumab Biosimilar – Anti-TNFRSF9, CD137 mAb – Research Grade Brand Logo
ID: BAB495098085

Urelumab Biosimilar – Anti-TNFRSF9, CD137 mAb – Research Grade, ProteoGenix, PX-TA1265

Description of Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb - Research Grade General information on Anti-TNFRSF9/CD137 [Homo sapiens] (Urelumab) Monoclonal Antibody Urelumab is a human antibody targeting CD137. Urelumab has been investigated for the treatment of Leukemia, Multiple Myeloma, Malignant Tumors, Cancer – Solid Tumors and B-Cell Non-Hodgkin’s Lymphoma.

Host

Reactivity

Applications

Conjugation

Request a product

Please provide the required information below so that we can quickly source your products.